Antioxidant and antigenotoxic role of recombinant human erythropoeitin against alkylating agents: Cisplatin and mitomycin C in cultured Vero cells
- 22 August 2013
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 238 (8) , 943-950
Abstract
Cisplatin (CDDP) and mitomycin C (MMC), two alkylating agents used against various solid tumours, are a common source of acute kidney injury. Thus, strategies for minimizing CDDP and MMC toxicity are of a clinical interest. In this study, we aimed to investigate the protective role of recombinant human erythropoietin (rhEPO) against oxidative stress and genotoxicity induced by CDDP and MMC in cultured Vero cells. Three types of treatments were performed: (i) cells were treated with rhEPO 24 h before exposure to CDDP/MMC (pre-treatment), (ii) cells were treated with rhEPO and CDDP/MMC simultaneously (co-treatment), (iii) cells were treated with rhEPO 24 h after exposure to CDDP/MMC (post-treatment). Our results showed that rhEPO decreased the reactive oxygen species levels, the malondialdehyde levels and ameliorated glutathione (reduced and oxidized glutathione) modulation induced by CDDP and MMC in cultured Vero cells. Furthermore, rhEPO administration prevented alkylating agents-induced DNA damage accessed by comet test. Altogether, our results suggested a protective role of rhEPO, against CDDP- and MMC-induced oxidative stress and genotoxicity, especially in pre-treatment condition.Keywords
This publication has 58 references indexed in Scilit:
- Assessment of cell viability, lipid peroxidation and quantification of DNA fragmentation after the treatment of anticancerous drug mitomycin C and curcumin in cultured human blood lymphocytesExperimental and Toxicologic Pathology, 2010
- Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplastyFibrogenesis & Tissue Repair, 2009
- Erythropoietin protects retinal pigment epithelial cells from oxidative damageFree Radical Biology and Medicine, 2009
- Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generationThe International Journal of Biochemistry & Cell Biology, 2009
- Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promiseKidney International, 2006
- Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing moleculeAmerican Journal of Physiology-Renal Physiology, 2006
- Mechanisms of Erythropoietin-induced Brain Protection in Neonatal Hypoxia-Ischemia Rat ModelJournal of Cerebral Blood Flow & Metabolism, 2004
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Involvement of H2O2Production in Cisplatin-Induced NephrotoxicityBiochemical and Biophysical Research Communications, 1998
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976